Call for Applications: PhD Program in Molecular Biomedicine

The Department of Science and Technology – Philippine Council for Health Research and Development (PCHRD), the University of Trieste (UNITS) and Fondazione Italiana Fegato (FIF) enter into an Agreement to develop and implement of a program focused on molecular hepatology within the PhD Program in Molecular Biomedicine of UNITS. This Fellowship program integrates basic research and clinics focusing on the study of molecular approaches to cancer biology, genetics, jaundice and metabolic diseases. The duration of the program is for 3 years.

Applicant’s research interests must be aligned with the National Unified Health Research Agenda (NUHRA) and National Harmonized Research and Development Agenda.

Objectives

The PhD program aims to achieve the following objectives:

Develop a pool of high-quality human resources in molecular hepatology in particular who will contribute to the country’s global competitiveness and economic development;
Provide opportunities to deserving students to study and obtain PhD degrees in Molecular Biomedicine in reputable institutions abroad;
Contribute to the country’s health research and technological innovation capabilities through training on biomedical research;
Create the basis for a Filipino Liver Network integrating basic and clinical research in liaison with FIF.

Capacity

Two positions of PhD students will be available each year at UNITS (Subject to the availability of funds)

Eligibility

The applicant must:

Be a Filipino citizen;
Be in good health condition;
Not be more than 40 years old at the time of application;
Hold a Master's degree in a field relevant to health and biomedicine;
Have an outstanding academic record;
Passed the admission requirements for the PhD study;
Passed the interview and other screening procedures;
Conduct her/his research for the entire duration of the scholarship and of the PhD Program.

Scholarship Privileges

Living allowance (20,000€/year);
Book allowance (500€/year);
Bench fee (4,000€/year);
Health and accident insurance; and
One round-trip economy fare from residence to Italy.

Selection Procedure

1^st Selection

Document Screening

Documentary evaluation of the form and other requirements by DOST-PCHRD

2^nd Selection

Technical Interview

Technical interview by a panel composed of DOST-PCHRD Director, FIF Scientific Director (or a FIF delegate), or a member of the PhD Program in Molecular Biomedicine of the UNITS, and other health research experts to assess:

· Academic background and learning ability

· Capacity for completing the study

· Possibility of contributing to the development of the country

· Compatibility to the university course

The interview will take place at DOST-PCHRD.

3^rd and Final Selection

A panel from the PhD Program in Molecular Biomedicine (UNITS) will identify the successful PhD student(s) from among the candidates selected in the Technical Interview, based on their academic records and the selection criteria as established by UNITS.

Timeline

March 17	Opening of the PCHRD Call for Applications
May 15	Application deadline
June - July	Document Screening, Interview, and Announcement of the selected candidate(s)
August - September	Preparation of necessary documents (visa, insurance, bank account)
November 1	Start of PhD program

List of Application Documents (Forms) for PCHRD screening

CV
Accomplished application form with ID picture
PSA Birth Certificate
Valid NBI Clearance
Endorsement Letter from two (2) former professors in MS program
Certificate of Employment (if employed, recommendation and permission to take a leave of absence from employer or head of agency while on scholarship)
Medical Certificate as to health status from a licensed physician with his/her PRC license number indicated
Certificate of Master Degree
Admission to Graduate Studies/Graduate School
Transcript of Records (certified true copy)
Program of Study/Course Curriculum (if available or to follow)
Re-entry Plan (narrative)
Budgetary Requirements (attach at least 3 airfare canvasses and website references for items requested)

Documents must be submitted to:

Address: Saliksik Building, DOST Compound, Gen. Santos Ave., Bicutan Taguig City 1631 Philippines

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: http://www.pchrd.dost.gov.ph/index.php/news/6524-call-for-applications-phd-program-in-molecular-biomedicine

Call for Proposals: Collaborative Research and Capacity Building Initiative in HIV and Schistosomiasis

One of the strategic objectives of Philippine National Health Research System (PNHRS) for 2019-2022 is to strengthen the capacity of the network to support health research. To address this objective, the PNHRS Capacity Building Committee (CBC) created the Collaborative Research and Capacity Building Initiative which will integrate the capacity building efforts of the implementing agencies, regional consortia, and member institutions. Harmonizing the efforts in research capacity will result in better use of resources which will contribute to the development of evidence-informed health decisions, programs, and policies.

The Collaborative Research and Capacity Building Initiative has the following objectives:

Promote partnership and collaboration among researchers/research and development institutions in health research capacity building;
Harmonize R&D capacity building efforts through interregional and interdisciplinary collaborative research;
Optimize resources for health R&D capacity building programs for researchers and research and development institutions; and
Develop more relevant and quality health researches aligned with National Unified Health Research Agenda (NUHRA) and Regional Unified Health Research Agenda.

Priority Areas for Funding

For its initial phase, the initiative accepts proposals on control and prevention of human immunodeficiency virus (HIV) and schistosomiasis.

The program must have at least 2-3 of the following research project components: (1) clinical/epidemiology/diagnostics, (2) use of ICT, (3) health social science, and (4) health policy and systems research.

Minimum Requirements for the Proposals

All proposals submitted for funding must comply with the following requirements:

Must involve the Research and Development Institution’s (RDI) or Higher Education Institutions’ (HEIs) faculty/researcher and early career scientists
Must include a mechanism for sharing of resources (expertise, data/information, facilities) for research
Must be collaborative, interregional, and interdisciplinary, involving 2-3 RDIs/HEIs through letter of support or willingness to collaborate
Must include plans for research dissemination, utilization, and translation
Duration: 1-2 years (PNHRS implementing agencies and counterpart implementing RDIs/non-RDIs shall provide funding for approved proposals for 1-2 years, subject to monitoring and evaluation and annual review)

Who may submit

Principal investigators must be a Filipino with at least a Master’s Degree in a relevant field and employed in universities/colleges, research agencies/institutes, hospitals, and other health related agencies who are members of the Regional Health Research and Development Consortia (RHRDC) are eligible to apply for the research grant.

How to submit

Interested lead proponents must submit their capsule proposals using the DOST-PCHRD forms to regional health research development consortium (RHRDCs).

Deadline of submission of capsule proposal to consortium is on or before April 30, 2020.

**Qualified capsule proposals will be endorsed by the RHRDC concerned to PNHRS CBC secretariat. The successful proponents will be invited to join a write-shop for the development of the full proposal.

For inquiries, you may email This email address is being protected from spambots. You need JavaScript enabled to view it." data-sanitized="mailto:This email address is being protected from spambots. You need JavaScript enabled to view it.">'+addy_text5861+'<\/a>'; //--> .

Source: http://www.pchrd.dost.gov.ph/index.php/news/6523-call-for-proposals-collaborative-research-and-capacity-building-initiative-in-hiv-and-schistosomiasis